What is CVE-2023-33365?

CVE-2023-33365 is a high-severity vulnerability in Supremainc Biostar_2, classified under Path Traversal. CVSS score: 7.5/10. Published 2023-08-03.

How severe is CVE-2023-33365?

High severity. CVSS v3 base score is 7.5 out of 10.

Path Traversal in Supremainc Biostar_2

CVE-2023-33365

A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.

Vulnerability class: Path Traversal (Directory Traversal)

EPSS: 0.007 (49.9th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

Affected products

Supremainc Biostar_2
N/a — versions n/a

Weakness classification (CWE)

CWE-22 — Path Traversal

References

cve@mitre.org (Release Notes, Vendor Advisory)
cve@mitre.org (Third Party Advisory)

Frequently asked questions

What is CVE-2023-33365?: CVE-2023-33365 is a high-severity vulnerability in Supremainc Biostar_2, classified under Path Traversal. CVSS score: 7.5/10. Published 2023-08-03.
How severe is CVE-2023-33365?: High severity. CVSS v3 base score is 7.5 out of 10.